Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Finished Goods (2023 - 2024)

Historic Finished Goods for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Q4 2024 value amounting to $2.5 million.

  • Zhengye Biotechnology Holding's Finished Goods rose 1965.09% to $2.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.5 million, marking a year-over-year increase of 1965.09%. This contributed to the annual value of $2.4 million for FY2024, which is 1557.21% up from last year.
  • Zhengye Biotechnology Holding's Finished Goods amounted to $2.5 million in Q4 2024, which was up 1965.09% from $2.1 million recorded in Q4 2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Finished Goods registered a high of $2.5 million during Q4 2024, and its lowest value of $2.1 million during Q4 2023.